Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 237.46 M101.96 M107.33 M-9.6 M104.78 M 304.48 M Research & development 122.92 M44.03 M43.85 M82.22 M94.1 M 264.21 M Operating income 663.47 M957.68 M1.08 B1.28 B1.44 B 4.75 B Non-Operating Income, Total -45.08 M-73.68 M-58.06 M-21.89 M-8.53 M -162.15 M Interest expense, net of interest capitalized 52.89 M51.41 M51.43 M—51.16 M — Non-Operating Income, excl. Interest Expenses -52.89 M-51.41 M-51.43 M-51.29 M-51.16 M -205.29 M Unusual income/expense 7.81 M-22.27 M-6.63 M29.4 M42.63 M 43.13 M Pretax income 618.39 M884 M1.02 B1.25 B1.43 B 4.59 B Equity in earnings ————— — Taxes 41.98 M112.15 M185.4 M151.1 M225.79 M 674.44 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 576.42 M771.86 M835.54 M1.1 B1.21 B 3.92 B Discontinued operations -147.12 M47.67 M000 47.67 M Net income 576.42 M819.53 M835.54 M1.1 B1.21 B 3.96 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 576.28 M819.33 M835.5 M1.1 B1.21 B 3.96 B Basic earnings per share (Basic EPS) 1.72.422.473.253.57 11.71 Diluted earnings per share (Diluted EPS) 1.672.392.453.243.56 11.64 Average basic shares outstanding 339.84 M338.62 M338.53 M338.78 M337.4 M — Diluted shares outstanding 344.88 M342.19 M340.97 M341.97 M338.73 M — EBITDA 743.36 M1 B1.11 B1.48 B1.47 B 5.08 B EBIT 663.47 M957.68 M1.08 B950.2 M1.44 B 4.43 B Cost of revenue 271.23 M155.08 M174.85 M183.53 M203.63 M 717.09 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 79.89 M47.05 M35.1 M32.74 M33.66 M 148.56 M